Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Increasing Muscle Mass May Aid Diabetics

By Biotechdaily staff writers
Posted on 21 May 2002
A study has shown that mice genetically altered to promote obesity but lacking the gene that codes for myostatin stay leaner and healthier and do not develop resistance to insulin. More...
Myostatin is a protein known to limit muscle growth. Conducted by researchers at the Johns Hopkins School of Medicine (Baltimore,MD, USA), the study was reported in the March 1, 2002, issue of the Journal of Clinical Investigation.

Previous studies have shown that mice without myostatin become muscle-bound "mighty mice.” Now the researchers show that mice without this protein, even mice that usually become obese, gain much less fat as they age. Regular and obese mice without myostatin gained less fat, as they got older, even though they ate about the same amounts of food as other mice. In fact, "mighty mice” outweighed their counterparts when young, but by 10 months of age weighed the same or less than other mice, which had bulked up with fat.

In people with type 2 diabetes, tissues--especially muscle--stop responding to insulin and therefore do not soak up sugar from the blood. Most current treatment strategies for diabetes target the insulin pathway. The new research suggests that an alternative approach might be to increase muscle mass, which may make the body more efficient at taking up sugar from the blood. The investigators caution that the team is studying genetic knockouts and does not yet know whether it will be possible to block myostatin in adult animals and see similar effects. In any case, myostatin-blocking agents still need to be developed.

"Some normal mice put on a lot of fat as they age and others not as much, but animals lacking myostatin do not put on much fat at all,” says Se Jin Lee, M.D., Ph.D., professor of molecular biology and genetics at Hopkins' Institute for Basic Biomedical Sciences. "This tells me that myostatin might be a useful target for preventing or treating obesity and associated conditions, like diabetes.”




Related Links:
Johns Hopkins

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Automatic CLIA Analyzer
Shine i6000
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.